Johnson & Johnson MedTech | Neurovascular

Thank you to Dr. Majidi for an incredible first week using the #CEREGLIDE? 92 Catheter System. It was amazing to see our first patient cases! Our #NTI Stroke Science was able to translate from bench to lab. Dr. Majidi shared, “CEREGLIDE? 92 and INNERGLIDE? 9 tracked to the M1 with ease.” A job well done all around – we are excited to continue to change the trajectory of stroke with our newly expanding CEREGLIDE? family. Learn More: https://bit.ly/499v2xO Important information: Prior to use, refer to the instructions for use supplied with this device for indications, contraindications, side effects, warnings and precautions. Caution: US law restricts this device to sale by or on the order of a physician. US_CNV_ISCH_392510.1

We are excited to share our latest findings from the MEMBRANE study, a prospective, multi-center, open-label, randomized control study including 376 randomized subjects in the United States and China for the treatment of chronic subdural hematoma. Finding: MEMBRANE study shows positive primary effectiveness endpoint which demonstrates positive treatment effect of middle meningeal artery embolization with TruFill? nBCA. #JnJMedTech #Stroke US_CNV_HEMO_393373.1

It has been non-stop at #SVIN24. Including the Women in Neurointervention breakfast, hands-on experience with our products at the Clot Workshop, Fellows Course, Posters Presentations, Innovation Suite and connecting at our booth. We are excited to showcase our product innovations in the neurovascular market. #JNJMedTech #stroke #SVIN24

Thank you #SVIN24 for a wonderful fellows session today! Always great to connect with our future learners to showcase our current and new technologies! #JNJMedTech #stroke

Thank you Drs. Al-Bayati, Al-Mufti and Ulfert for an educational CLOTS workshop session today! It was great to hear about the recent #NTI science and research, your techniques on overcoming challenging anatomy and your experience with our technology! Your insights and tips will help us all to change the trajectory of stroke together! #CEREGLIDE #EMBOTRAP #EMBOGUARD

Day #1 at #SVIN24 in San Diego ?? Our team is excited to share how Johnson & Johnson MedTech is contributing to the field of interventional and therapeutic neuroradiology. Stop by booth for an update on our many activities during the event. #Stroke #JnJMedTech

The CEREGLIDE? 71 Intermediate Catheter with TruCourse? Technology is now available in a 115cm length. Designed for a variety of hemorrhagic procedures**, this catheter offers reliable trackability and support* and inner diameter allows room for multiple devices, giving you options. Learn More: https://bit.ly/47fcn1L *More trackable than Sofia Plus, React 71, Catalyst 6 and Large Bore Catheter based on physician evaluation in a clinically relevant silicone flow model. Lower Track forces in a clinically relevant silicone flow model compared to Zoom 71. **Important information: Prior to use, refer to the instructions for use supplied with this device for indications, contraindications, side effects, warnings and precautions. US_CNV_ISCH_391191

Join us at #SVIN24 on November 22nd at 10:30AM to 10:40AM for the latest MEMBRANE study results presented by Dr. Ansaar Rai. Dr. Rai is compensated by and presenting on behalf of J&J MedTech, and must present information in accordance with applicable regulatory requirements.

Join Dr. Fernando Vinuela as he shares his journey through interventional neuroradiology in our latest episode of “Neuro Innovation Talks” podcast. @DeviceTalks Watch Now: https://bit.ly/4eA3NND Series: https://bit.ly/40Mj6zR

We're headed to sunny San Diego ?? November 20-22 for @svinsociety! Our team is excited to share how Johnson & Johnson MedTech is contributing to the field of interventional and therapeutic neuroradiology.